Market Overview:
The global label free detection market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for label free detection instruments, consumables, biosensor chips and microplates from contract research organizations (CRO), pharmaceutical and biotechnology companies, academic research institutes and others. Additionally, the growing focus on personalized medicine is also propelling the demand for label free detection technologies across the globe. However, high cost of instruments and lack of skilled professionals are some of the major factors restraining the growth of this market.
Product Definition:
Label free detection is the ability to detect molecules without attaching a label. This is important because it allows scientists to study the biology of a molecule without affecting its behavior.
Instruments:
Instruments are devices or systems that help in measuring, detecting and analyzing various attributes of living organisms. They are used for the measurement and detection of genetic characteristics such as DNA sequence, protein structure, gene expression level among others. Instruments have been playing a pivotal role in the development of new diagnostic techniques over the past few decades.
Consumables:
Consumables are the tools or devices that are required to perform a specific task. In label free detection market, consumables include labels, tapes and other similar items. They are used by manufacturers of automated labeling equipment for labeling products in packaging lines without using any labels on the product or its container.
Application Insights:
The contract research organizations (CRO) application segment dominated the global label free detection market in 2017. This can be attributed to the increasing usage of bioanalytical equipment and consumables by CROs for drug discovery & development. The growing importance of bioanalytical techniques in drug discovery is expected to drive the demand for LC-MS/MS instruments, which will help companies operating in this sector attain higher growth potential over the forecast period.
In addition, a rise in R&D expenditure by pharmaceutical and biotechnology companies has led to an increased focus on developing novel drugs with better therapeutic efficacy at reduced costs coupled with high quality standards is anticipated to further boost industry growth over the next eight years. Furthermore, government initiatives such as ¢â‚¬Å“Make In India¢â‚¬ are likely to increase investments by Indian pharmaceutical and biotechnology companies which will further propel industry expansion over there during 2018-2030 period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing investments in R&D, and high adoption rate for novel technologies. The region is expected to maintain its dominance throughout the forecast period owing to continuous innovations and technological advancements coupled with increased funding for research activities from government agencies and private companies.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing economy, rising disposable income levels among people along with rapid developments in healthcare infrastructure & spending on R&D by various organizations including governments & biotechnology firms looking for new treatment options or therapies that can help them treat diseases more efficiently & effectively at lesser cost. These factors are expected favorably impact overall market development during the estimated time span.
Growth Factors:
- Increasing demand for point-of-care diagnostics: The growing demand for rapid, accurate, and cost-effective diagnostic tests is driving the market for label free detection. This technology offers several advantages over traditional methods such as high sensitivity and specificity, low assay time, and ease of use.
- Advances in nanotechnology: The development of novel nanotechnologies is facilitating the miniaturization of detection devices, which is helping to drive down the cost of label free detection systems. Additionally, these technologies are enabling the development of more sensitive and specific assays that can detect smaller targets with greater accuracy.
- Growing interest in personalized medicine: As healthcare providers shift towards a more personalized approach to medicine, there is increasing demand for diagnostic tests that can help identify individual patients’ risk factors and provide tailored treatment plans accordingly. Label free detection systems are well suited to this task as they offer high specificity and sensitivity coupled with fast assay times.
Scope Of The Report
Report Attributes
Report Details
Report Title
Label Free Detection Market Research Report
By Type
Instruments, Consumables, Biosensor chips, Microplates
By Application
Contract Research Organizations (CRO), Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Others
By Companies
Bio-Rad Laboratories, General Electric, Bioptix, Attana, Ametek, Inc, Corning, Inc, Pall Corporation, Danaher Corporation, X-body Biosciences, Roche Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Label Free Detection Market Report Segments:
The global Label Free Detection market is segmented on the basis of:
Types
Instruments, Consumables, Biosensor chips, Microplates
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Contract Research Organizations (CRO), Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad Laboratories
- General Electric
- Bioptix
- Attana
- Ametek, Inc
- Corning, Inc
- Pall Corporation
- Danaher Corporation
- X-body Biosciences
- Roche Diagnostics
Highlights of The Label Free Detection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Consumables
- Biosensor chips
- Microplates
- By Application:
- Contract Research Organizations (CRO)
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Label Free Detection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Label free detection is a technique used in digital imaging and signal processing to identify objects or features in an image without labeling them.
Some of the major companies in the label free detection market are Bio-Rad Laboratories, General Electric, Bioptix, Attana, Ametek, Inc, Corning, Inc, Pall Corporation, Danaher Corporation, X-body Biosciences, Roche Diagnostics.
The label free detection market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Label Free Detection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Label Free Detection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Label Free Detection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Label Free Detection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Label Free Detection Market Size & Forecast, 2020-2028
4.5.1 Label Free Detection Market Size and Y-o-Y Growth
4.5.2 Label Free Detection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Biosensor chips
5.2.4 Microplates
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Contract Research Organizations (CRO)
6.2.2 Pharmaceutical and Biotechnology Companies
6.2.3 Academic Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Label Free Detection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Label Free Detection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Consumables
9.6.3 Biosensor chips
9.6.4 Microplates
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Contract Research Organizations (CRO)
9.10.2 Pharmaceutical and Biotechnology Companies
9.10.3 Academic Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Consumables
10.6.3 Biosensor chips
10.6.4 Microplates
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Contract Research Organizations (CRO)
10.10.2 Pharmaceutical and Biotechnology Companies
10.10.3 Academic Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Consumables
11.6.3 Biosensor chips
11.6.4 Microplates
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Contract Research Organizations (CRO)
11.10.2 Pharmaceutical and Biotechnology Companies
11.10.3 Academic Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Consumables
12.6.3 Biosensor chips
12.6.4 Microplates
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Contract Research Organizations (CRO)
12.10.2 Pharmaceutical and Biotechnology Companies
12.10.3 Academic Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Consumables
13.6.3 Biosensor chips
13.6.4 Microplates
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Contract Research Organizations (CRO)
13.10.2 Pharmaceutical and Biotechnology Companies
13.10.3 Academic Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Label Free Detection Market: Competitive Dashboard
14.2 Global Label Free Detection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 General Electric
14.3.3 Bioptix
14.3.4 Attana
14.3.5 Ametek, Inc
14.3.6 Corning, Inc
14.3.7 Pall Corporation
14.3.8 Danaher Corporation
14.3.9 X-body Biosciences
14.3.10 Roche Diagnostics
